205 related articles for article (PubMed ID: 27151546)
21. An update on topical therapies for mild-moderate psoriasis.
van de Kerkhof PC
Dermatol Clin; 2015 Jan; 33(1):73-7. PubMed ID: 25412784
[TBL] [Abstract][Full Text] [Related]
22. Methodologies for medication adherence evaluation: Focus on psoriasis topical treatment.
Teixeira A; Teixeira M; Almeida V; Torres T; Sousa Lobo JM; Almeida IF
J Dermatol Sci; 2016 May; 82(2):63-8. PubMed ID: 26917347
[TBL] [Abstract][Full Text] [Related]
23. Are topical corticosteroids useful adjunctive therapy for the treatment of psoriasis with ultraviolet radiation? A review of the literature.
Meola T; Soter NA; Lim HW
Arch Dermatol; 1991 Nov; 127(11):1708-13. PubMed ID: 1952979
[TBL] [Abstract][Full Text] [Related]
24. Adherence to medication in patients with psoriasis: a systematic literature review.
Thorneloe RJ; Bundy C; Griffiths CE; Ashcroft DM; Cordingley L
Br J Dermatol; 2013 Jan; 168(1):20-31. PubMed ID: 22963128
[TBL] [Abstract][Full Text] [Related]
25. Association Between Method of Prescribing and Primary Nonadherence to Dermatologic Medication in an Urban Hospital Population.
Adamson AS; Suarez EA; Gorman AR
JAMA Dermatol; 2017 Jan; 153(1):49-54. PubMed ID: 27784045
[TBL] [Abstract][Full Text] [Related]
26. Topical treatment for scalp psoriasis: Comparison of patient preference, quality of life and efficacy for non-alcoholic mometasone emulsion versus calcipotriol/betamethasone gel in daily clinical practice.
Gual A; Pau-Charles I; Molin S
J Dermatolog Treat; 2016; 27(3):228-34. PubMed ID: 26503824
[TBL] [Abstract][Full Text] [Related]
27. Development and Validation of a Novel Questionnaire for Adherence with Topical Treatments in Psoriasis (QATOP).
Teixeira A; Oliveira C; Teixeira M; Rita Gaio A; Lobo JMS; de Almeida IFM; Almeida V
Am J Clin Dermatol; 2017 Aug; 18(4):571-581. PubMed ID: 28321796
[TBL] [Abstract][Full Text] [Related]
28. Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.
Daudén E; Bewley A; Lambert J; Girolomoni G; Cambazard F; Reich K
J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():22-32. PubMed ID: 24684740
[TBL] [Abstract][Full Text] [Related]
29. Vitamine D analogue-based therapies for psoriasis.
O'Neill JL; Feldman SR
Drugs Today (Barc); 2010 May; 46(5):351-60. PubMed ID: 20517536
[TBL] [Abstract][Full Text] [Related]
30. [Non adherence and topical steroids].
Aubert H; Barbarot S
Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S7-12. PubMed ID: 22305285
[TBL] [Abstract][Full Text] [Related]
31. New developments in topical sequential therapy for psoriasis.
Koo JY
Skin Therapy Lett; 2005 Nov; 10(9):1-4. PubMed ID: 16292458
[TBL] [Abstract][Full Text] [Related]
32. Psoriasis treatment in the United States at the end of the 20th century.
Pearce DJ; Stealey KH; Balkrishnan R; Fleischer AB; Feldman SR
Int J Dermatol; 2006 Apr; 45(4):370-4. PubMed ID: 16650160
[TBL] [Abstract][Full Text] [Related]
33. Assessment of medication adherence and treatment satisfaction in Japanese patients with psoriasis of various severities.
Ichiyama S; Ito M; Funasaka Y; Abe M; Nishida E; Muramatsu S; Nishihara H; Kato H; Morita A; Imafuku S; Saeki H
J Dermatol; 2018 Jun; 45(6):727-731. PubMed ID: 29356075
[TBL] [Abstract][Full Text] [Related]
34. Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy.
Gorgievska Sukarovska B; Lipozencić J
Acta Dermatovenerol Croat; 2006; 14(3):188-96. PubMed ID: 17010269
[TBL] [Abstract][Full Text] [Related]
35. Topical treatments for scalp psoriasis: summary of a Cochrane Systematic Review.
Schlager JG; Rosumeck S; Werner RN; Jacobs A; Schmitt J; Schlager C; Nast A
Br J Dermatol; 2017 Mar; 176(3):604-614. PubMed ID: 27312814
[TBL] [Abstract][Full Text] [Related]
36. Frequency of Primary Nonadherence to Acne Treatment.
Anderson KL; Dothard EH; Huang KE; Feldman SR
JAMA Dermatol; 2015 Jun; 151(6):623-6. PubMed ID: 25793290
[TBL] [Abstract][Full Text] [Related]
37. [Topical treatment adherence for psoriasis].
Halioua B
Rev Prat; 2012 Feb; 62(2):156-9. PubMed ID: 22408849
[No Abstract] [Full Text] [Related]
38. Poor medication adherence in patients with psoriasis and a successful intervention.
Wang W; Qiu Y; Zhao F; Zhang F
J Dermatolog Treat; 2019 Sep; 30(6):525-528. PubMed ID: 29790405
[No Abstract] [Full Text] [Related]
39. Prescription-level factors associated with primary nonadherence to dermatologic medications.
Rutherford A; Glass DA; Suarez EA; Adamson AS
J Dermatolog Treat; 2018 May; 29(3):300-304. PubMed ID: 28783420
[TBL] [Abstract][Full Text] [Related]
40. A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP).
Reich K; Zschocke I; Bachelez H; de Jong EMGJ; Gisondi P; Puig L; Warren RB; Ortland C; Mrowietz U;
Br J Dermatol; 2017 Jul; 177(1):197-205. PubMed ID: 28301043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
